Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations
- PMID: 27918719
- DOI: 10.1200/JCO.2016.70.1607
Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations
Comment in
-
Reply to A. Wang-Gillam et al.J Clin Oncol. 2017 Feb 20;35(6):690-691. doi: 10.1200/JCO.2016.70.7463. Epub 2016 Dec 5. J Clin Oncol. 2017. PMID: 27918714 No abstract available.
Comment on
-
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol. 2016 Aug 10;34(23):2784-96. doi: 10.1200/JCO.2016.67.1412. Epub 2016 May 31. J Clin Oncol. 2016. PMID: 27247222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical